EN
HI
Piramal Pharma share price chart
Piramal Pharma Share Key Metrics
Volume
27.21 L
Market Cap
27990.26 CR
LTQ@LTP
44@210.24
ATP
212.24
Var Margin
18.41 %
Circuit Range
171.36-257.02
Delivery %
42.25 %
Value
57.75 CR
ASM/GSM
No
Market Lot
1
Summary
PPLPHARMA stock price is ₹210.24 as of 13 Aug, 2026. The stock intraday movement has stayed between ₹209.00 and ₹216.96, while Piramal Pharma share price 52 week high low is ₹132.30 & ₹218.50.
In terms of trading activity, PPLPHARMA share price has recorded a volume of 27,20,946 shares. The Piramal Pharma has a market cap of ₹1331348130. The stock’s Average Traded Price (ATP) stands at ₹212.24, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 44 @ ₹210.24.
The Piramal Pharma upper circuit limit is ₹257.02 & The Piramal Pharma lower circuit limit is ₹171.36, with a Value of ₹57.75 CR. The Delivery Percentage for the day is 42.25%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Piramal Pharma Fundamentals
P/E Ratio
0
P/B Ratio
3.56
Div. Yield
0
Sector P/E
65.02
Sector P/B
3.32
Sec. Div. Yield
0.51
Piramal Pharma Resistance and Support
Pivot 215.01
Resistance
First Resistance
217.04
Second Resistance
219.88
Third Resistance
221.91
Support
First Support
212.17
Second Support
210.14
Third Support
207.3
Piramal Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Aug 12 2026 | 214.2 | 210.24 | -1.84% | 216.96 | 209 |
| Tue Aug 11 2026 | 214.78 | 214.19 | 0.27% | 217.85 | 212.97 |
| Mon Aug 10 2026 | 209.55 | 213.61 | 1.94% | 218.5 | 209.55 |
Piramal Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-29 | Quarterly Results |
| 2026-04-28 | Audited Results |
| 2026-01-28 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-07-28 | Quarterly Results |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
| 2024-10-23 | Quarterly Results |
Piramal Pharma News
Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 -Resumption Of Operations At Company'S Facilities Located At Ahmedabad, Gujarat
Piramal Pharma has resumed operations at its manufacturing facilities in Ahmedabad, which were temporarily suspended due to heavy rainfall. The company does not expect any material impact on its operations or financial performance.
Aug 03 2026 17:29:20
Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Temporary Suspension Of Operations At Company'S Facilities Located At Ahmedabad, Gujarat.
Piramal Pharma temporarily suspended operations at its Ahmedabad manufacturing facilities due to heavy rainfall and flooding. The affected units contribute less than 3% of consolidated revenues, and operations are expected to normalize within days.
Jul 24 2026 20:42:25
Read More
Piramal Pharma Management
| Name | Position |
|---|---|
| Nandini Piramal | Chairperson |
| Maneesh Sharma | Company Secretary and Compliance Officer |
Piramal Pharma Similar Stocks
Krishna Institute of Medical Sciences Ltd
803.95
-9.10 (1.12%)
Dr. Lal Pathlabs Ltd.
1953.30
3.40 (0.17%)
Wockhardt Ltd.
1847.40
-62.00 (3.25%)
Sai Life Sciences Ltd.
1463.60
19.20 (1.33%)
Neuland Laboratories Ltd.
22510.00
-445.00 (1.94%)
Acutaas Chemicals Ltd.
3153.40
-92.60 (2.85%)
Pfizer Ltd.
5017.60
119.10 (2.43%)
Granules India Ltd.
864.80
3.80 (0.44%)
Caplin Point Laboratories Ltd.
2472.40
-157.20 (5.98%)
Eris Lifesciences Ltd.
1351.70
-38.60 (2.78%)
Piramal Pharma FAQs
The Buying Price of Piramal Pharma share is 210.24 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Piramal Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Piramal Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Piramal Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Piramal Pharma shares is 3.56. Useful to assess the stock's value relative to its book value.
To assess Piramal Pharma’s valuation compare Sector P/E, P/B which are 65.02 & 3.32 with sector averages, along with growth rates and financial metrics.
The Market Cap of Piramal Pharma is 27990.26 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Piramal Pharma share price is 218.50 & 132.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Piramal Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
